(Q34792334)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24912408%20AND%20SRC:MED&resulttype=core&format=json

20 March 2020

title

Initial testing (stage 1) of glembatumumab vedotin (CDX-011) by the pediatric preclinical testing program (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24912408%20AND%20SRC:MED&resulttype=core&format=json

20 March 2020

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24912408%20AND%20SRC:MED&resulttype=core&format=json

20 March 2020

Malcolm A Smith

series ordinal

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24912408%20AND%20SRC:MED&resulttype=core&format=json

20 March 2020

6

Peter J Houghton

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24912408%20AND%20SRC:MED&resulttype=core&format=json

20 March 2020

5

Raushan T Kurmasheva

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24912408%20AND%20SRC:MED&resulttype=core&format=json

20 March 2020

1

E Anders Kolb

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24912408%20AND%20SRC:MED&resulttype=core&format=json

20 March 2020

3

Catherine A Billups

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24912408%20AND%20SRC:MED&resulttype=core&format=json

20 March 2020

author name string

Thomas Hawthorne

series ordinal

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24912408%20AND%20SRC:MED&resulttype=core&format=json

20 March 2020

publication date

9 June 2014

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24912408%20AND%20SRC:MED&resulttype=core&format=json

20 March 2020

published in

Pediatric Blood Cancer

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24912408%20AND%20SRC:MED&resulttype=core&format=json

20 March 2020

volume

61

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24912408%20AND%20SRC:MED&resulttype=core&format=json

20 March 2020

issue

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24912408%20AND%20SRC:MED&resulttype=core&format=json

20 March 2020

page(s)

1816-1821

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24912408%20AND%20SRC:MED&resulttype=core&format=json

Initial testing (stage 1) of eribulin, a novel tubulin binding agent, by the pediatric preclinical testing program

20 March 2020

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4280502

Glycoprotein nonmetastatic B is an independent prognostic indicator of recurrence and a novel therapeutic target in breast cancer

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4280502

Pharmacologically enhanced expression of GPNMB increases the sensitivity of melanoma cells to the CR011-vcMMAE antibody-drug conjugate

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4280502

Gpnmb is a melanosome-associated glycoprotein that contributes to melanocyte/keratinocyte adhesion in a RGD-dependent fashion

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4280502

Antibody-drug conjugates for cancer therapy

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4280502

Osteoactivin/HGFIN: is it a tumor suppressor or mediator of metastasis in breast cancer?

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4280502

Treatment parameters modulating regression of human melanoma xenografts by an antibody-drug conjugate (CR011-vcMMAE) targeting GPNMB.

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4280502

Gpnmb is induced in macrophages by IFN-gamma and lipopolysaccharide and acts as a feedback regulator of proinflammatory responses

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4280502

Evaluation of ABT-751 against childhood cancer models in vivo

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4280502

DC-HIL is a negative regulator of T lymphocyte activation

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4280502

Glycoprotein nonmetastatic melanoma protein B, a potential molecular therapeutic target in patients with glioblastoma multiforme

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4280502

CR011, a fully human monoclonal antibody-auristatin E conjugate, for the treatment of melanoma

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4280502

mRNA expression of the murine glycoprotein (transmembrane) nmb (Gpnmb) gene is linked to the developing retinal pigment epithelium and iris

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4280502

Vinorelbine in previously treated advanced childhood sarcomas: evidence of activity in rhabdomyosarcoma

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4280502

Randomised trial of two regimens of chemotherapy in operable osteosarcoma: a study of the European Osteosarcoma Intergroup

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4280502

Adjuvant chemotherapy for osteosarcoma: a randomized prospective trial

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4280502

Adjuvant chemotherapy for osteosarcoma of the extremity. Long-term results of two consecutive prospective protocol studies

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4280502

The immune inhibitory receptor osteoactivin is upregulated in monocyte-derived dendritic cells by BCR-ABL tyrosine kinase inhibitors.

8 July 2018

1 reference

Crossref

https://api.crossref.org/works/10.1002%2FPBC.25099

Osteoactivin expressed during cirrhosis development in rats fed a choline-deficient, l-amino acid-defined diet, accelerates motility of hepatoma cells

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1002%2FPBC.25099

The pediatric preclinical testing program: description of models and early testing results.

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1002%2FPBC.25099

Evaluation of chemotherapy in children with metastatic Ewing's sarcoma and osteogenic sarcoma

21 January 2018

1 reference

12 December 2020

Vincristine (NSC-67574) therapy for malignant solid tumors in children (except Wilms' tumor)

1 reference

12 December 2020

A controlled pilot study of high-dose methotrexate as postsurgical adjuvant treatment for primary osteosarcoma

1 reference

12 December 2020

A randomized study comparing high-dose methotrexate with moderate-dose methotrexate as components of adjuvant chemotherapy in childhood nonmetastatic osteosarcoma: a report from the Childrens Cancer Study Group

1 reference

12 December 2020

Syndecan-4 mediates the coinhibitory function of DC-HIL on T cell activation

1 reference

12 December 2020

Osteogenic sarcoma: eight-percent, three-year, disease-free survival with combination chemotherapy (T-7)

1 reference

12 December 2020

Identifiers

DOI

10.1002/PBC.25099

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24912408%20AND%20SRC:MED&resulttype=core&format=json

20 March 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24912408%20AND%20SRC:MED&resulttype=core&format=json

20 March 2020

PubMed publication ID

24912408

1 reference